Ram M. Jagannath
Principal, U.S. Buyout, The Carlyle Group
clinical research
PPD
Netherlands
Biography
Ram M. Jagannath is a principal with Carlyle’s U.S. buyout group, focusing on investment opportunities in the health care sector. He is based in New York. Since joining Carlyle in 2007, Mr. Jagannath has been actively involved with Carlyle’s investments in Pharmaceutical Product Development (PPD), Ortho Clinical Diagnostics (OCD), Healthscope Limited and HCR-Manor Care. Prior to joining Carlyle, Mr. Jagannath was with Genstar Capital and Thomas Weisel Capital Partners (now Tailwind Capital) in San Francisco. Mr. Jagannath received an MBA from the Kellogg School of Management, a J.D. from Northwestern University School of Law and a B.S.E. in biomedical and electrical engineering from Duke University, where he was a Fulbright Scholar. Mr. Jagannath is a member of the board of directors of PPD and Ortho Clinical Diagnostics, and he is also a term member at the Council on Foreign Relations.
Research Interest
Health care
